fluorodeoxyglucose f18 has been researched along with zoledronic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Khuri, F; Saba, N | 1 |
| Frerich, B; Hemprich, A; Kluge, R; Sabri, O; Schulz, T; Steinhoff, K; Wilde, F; Winter, K | 1 |
| Chan, KC; Fleisher, KE; Friedman, KP; Glickman, RS; Gupta, V; Janal, M; Mourtzikos, KA; Raad, RA; Rakheja, R | 1 |
| Cappetta, A; Evangelista, L; Opocher, G; Pastorelli, D; Spano, L; Zovato, S | 1 |
| Ishii, S; Kikuchi, K; Miyajima, M; Sakuma, K; Shishido, F | 1 |
| Bassa, P; Capdevila, L; Garcia, JR; Pérez, C; Ramos, F; Valenti, V | 1 |
| Fujiwara, K; Ishida, H; Kanamitsu, K; Shimada, A; Tsukahara, H; Washio, K | 1 |
1 review(s) available for fluorodeoxyglucose f18 and zoledronic acid
| Article | Year |
|---|---|
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clodronic Acid; Diphosphonates; Etidronic Acid; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Ibandronic Acid; Imidazoles; Lung Neoplasms; Pamidronate; Positron-Emission Tomography; Predictive Value of Tests; Therapeutic Equivalency; Zoledronic Acid | 2005 |
6 other study(ies) available for fluorodeoxyglucose f18 and zoledronic acid
| Article | Year |
|---|---|
Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imidazoles; Jaw Diseases; Male; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Zoledronic Acid | 2009 |
Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Topics: Aged; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Cross-Sectional Studies; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Male; Mandible; Mandibular Diseases; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Bitewing; Radiography, Panoramic; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tooth Extraction; Zoledronic Acid | 2014 |
Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid.
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome; Zoledronic Acid | 2015 |
VALIDATION OF THERAPEUTIC RESPONSE ASSESSMENT BY BONE SCINTIGRAPHY IN PATIENTS WITH BONE-ONLY METASTATIC BREAST CANCERS DURING ZOLEDRONIC ACID TREATMENT: COMPARISON WITH COMPUTED TOMOGRAPHY ASSESSMENT.
Topics: Adult; Aged; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Zoledronic Acid | 2015 |
18F-FDG PET/CT in the Staging and Management of Breast Cancer: Value in Disease Outcome and Planning Therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Axilla; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorodeoxyglucose F18; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Letrozole; Lymph Node Excision; Lymph Nodes; Mastectomy; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy; Ribs; Taxoids; Triazoles; Zoledronic Acid | 2017 |
A case of alveolar rhabdomyosarcoma showing concurrent responsive bone marrow lesions and refractory pancreatic lesions to pazopanib monotherapy.
Topics: Adolescent; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Neoplasms; Fluorodeoxyglucose F18; Forkhead Box Protein O1; Humans; Indazoles; Oncogene Proteins, Fusion; Paired Box Transcription Factors; Pancreatic Neoplasms; PAX3 Transcription Factor; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma, Alveolar; Sulfonamides; Tumor Microenvironment; Zoledronic Acid | 2020 |